Ablation Equipments Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Ablation Equipments Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Ablation Equipments pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Ablation Equipments are the devices, used to surgically remove a body tissue.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Ablation Equipments under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Ablation Equipments and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Ablation Equipments under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Ablation Equipments Overview
Products under Development
Ablation Equipments - Pipeline Products by Stage of Development
Table Figure 1: Ablation Equipments - Pipeline Products by Stage of Development
Table Ablation Equipments - Pipeline Products by Stage of Development
Ablation Equipments - Pipeline Products by Territory
Table Figure 2: Ablation Equipments - Pipeline Products by Territory
Table Ablation Equipments - Pipeline Products by Territory
Ablation Equipments - Pipeline Products by Regulatory Path
Table FocalPoint Ablation System - Product Description
Table Avenda Health Inc - Ongoing Clinical Trials Overview
Table FocalPoint Ablation System - Office-based Focal Laser Ablation of Prostate Cancer: An Early Feasibility Study Using MRI/US Image Fusion for Guidance
Baird Medical Investment Holdings Ltd Company Overview
Table Broncus Medical Inc - Ongoing Clinical Trials Overview
Table RF-SEG Generator + RF-iCon Ablation Catheter (RF-II) - A Multicenter, Single Group Target Value Clinical Study to Evaluate Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors
Corveus Medical Inc Company Overview
Corveus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Fractyl Health Inc - Ongoing Clinical Trials Overview
Table Revita DMR System - A Prospective, Randomized, Double-blind, Sham-controlled, Multi-center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita System in Subjects with Type 2 Diabetes on Insulin Therapy
Table Revita DMR System - A Randomized Double-blind Sham-controlled Trial to Evaluate Efficacy+Safety of Revita Duodenal Mucosal Resurfacing (DMR) Treatment Paradigm+Retreatment in Patients With Type 2 Diabetes Using Non-insulin Glucose Lowering Medications (REMIND)
Table Revita DMR System - Pivotal Study to Evaluate the Efficacy of Revita DMR System in Patients with Type 2 Diabetes (T2D): Revitalize-2
Francis Medical Inc Company Overview
Francis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Francis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Vanquish System - Prostate Cancer - Product Status
Table Vanquish System - Prostate Cancer - Product Description
Table Francis Medical Inc - Ongoing Clinical Trials Overview
Table Vanquish System - Prostate Cancer - Prospective, Multicenter, Single-Arm Study of Vanquish Water Vapor Ablation for Prostate Cancer
Table Aliya PEF System - NSCLC - A Clinical Study of Aliya Pulsed Electric Fields (PEF) Delivered Prior to Standard of Care Treatment for Advanced Cancer
Table Aliya PEF System - NSCLC - Safety and Clinical Efficacy Evaluation of Pulsed Electric Field Therapy in Patients with Late-stage Non-small Cell Lung Cancer
Table Aliya PEF System - NSCLC - The Galvanize Therapeutics Early Stage, Non-Small Cell Lung Cancer, Treat and Resect Study
Guangdong Hygeia Medical Devices Manufacturing Co Ltd Company Overview
Guangdong Hygeia Medical Devices Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Guangdong Hygeia Medical Devices Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Cold And Heat Ablation System - Product Status
Table Cold And Heat Ablation System - Product Description
Harmonic Medical Inc Company Overview
Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Harmonic Medical Inc - Ongoing Clinical Trials Overview
Table Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - MRI-guided High Intensity Focused Ultrasound Ablation of Leiomyomas. Single Arm, Feasibility Study Using the Symphony - MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas
HEPTA Medical SASU Company Overview
HEPTA Medical SASU Pipeline Products & Ongoing Clinical Trials Overview
Table ETLA System - The REDUCE Study – Safety of the Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Severe Emphysema with hyperinflation – A First in Human Study (CSP-11121)
NeuroOne Medical Technologies Corp Company Overview
Table Intervapor System - Emphysema - Product Status
Table Intervapor System - Emphysema - Product Description
Table Uptake Medical Technology Inc - Ongoing Clinical Trials Overview
Table Intervapor System - Emphysema - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation
Table Intervapor System - Emphysema - Post-Market BTVA Registry for Patients with Emphysema Treated with BTVA
Table Intervapor System - Emphysema - Post-market Registry for Patients with Emphysema Treated with BTVA in India
Table Intervapor System - Emphysema - Targeted Segmental Vapor Ablation Treatment of Emphysema with Upper Lobe Predominance: A Randomized Controlled Trial of InterVapor in France - The TARGET Trial
Washington University in St. Louis Company Overview
Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview
Table Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview
Table Thermoablation Probe - Product Status(Washington University in St. Louis)
Table Thermoablation Probe - Product Description(Washington University in St. Louis)
Ablation Equipments- Recent Developments
Nov 23, 2023: BaiDe (Suzhou) Medical Receives 510(K) Clearance For Microwave Ablation System (BD-GT)
Nov 22, 2023: Baird Medical wins FDA clearance for microwave ablation system
Nov 10, 2023: HC Surgical Specialists Announces Change of Registered Office Address
Nov 07, 2023: NeuroOne Provides Progress Update on FDA 510 (k) Submission for OneRF Ablation System
Nov 06, 2023: Galvanize Therapeutics Announces Promising Data on the Aliya Pulsed Electric Field (PEF) System in Early-Stage Non-Small Cell Lung Cancer
Oct 25, 2023: HSS Appoints New Leadership in Neurology and Anesthesia
Oct 09, 2023: Stryker to Host Investor Day
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer
Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
Sep 28, 2023: Fractyl Health to Present Pioneering Data on Revita and Rejuva Programs at the European Association for the Study of Diabetes (EASD) 2023 Scientific Congress
Sep 21, 2023: Galvanize Therapeutics commences Aliya PEF System trial
Sep 21, 2023: Relievant Medsystems Introduces Intracept Simulator System Powered by Medability for Improved and Expanded Physician Training Opportunities
Sep 18, 2023: Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long- Term Efficacy in Patients
Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board
Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business
Sep 14, 2023: Smith & Nephew Announces Board Changes
Sep 12, 2023: Relievant Medsystems Announces Pooled Analysis Demonstrating the Intracept Procedure Significantly Reduces Low Back Pain-related Healthcare Utilization
Sep 11, 2023: HC Surgical Specialists Notice of Annual General Meeting
Sep 05, 2023: Baird Medical’s Single-Use Sterile Biopsy Needle Receives Approval From Jiangsu Medical Products Administration in China
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 10, 2023: Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation
Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
Aug 01, 2023: Fractyl Health Announces Clinical Update on Revita Real World Registry in Germany and Launch of Revita+ Telehealth Program Combining Behavioral Recommendations with Revita Treatment for Type 2 Diabetes
Aug 01, 2023: Francis Medical Receives U.S. FDA Breakthrough Device Designation for Vanquish Minimally Invasive Prostate Cancer Therapy
Jul 20, 2023: Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure
Jul 19, 2023: NMPA green lights Class III registered microwave ablation needle
Jul 12, 2023: ArthroCare Receives an Additional 510(k) Clearance for Werewolf Coblation System
Jul 12, 2023: ArthroCare Receives an Additional 510(k) Clearance for Werewolf+ Coblation System
Jul 11, 2023: Compal Electronics Receives 510(k) Clearance for AblatePal RF Ablation System
Jun 26, 2023: Fractyl Health Reports Durable Improvement in Glucose Control, Weight Loss, and Insulin Reduction in T2D Patients Using Revita in Open Label Phase of Revitalize 1 Pivotal Study at the American Diabetes Association 83rd Scientific Sessions
Jun 20, 2023: Relievant Medsystems Announces Favorable Coverage Policy From Cigna Healthcare for the Intracept Procedure
Jun 15, 2023: Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients
Jun 13, 2023: HSS Appoints Mary E. Cassai, RN to Executive Vice President, Chief Operating Officer
Jun 12, 2023: NeuroOne Submits 510(k) Application to FDA for OneRF Ablation System
May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023
May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
May 09, 2023: Relievant Medsystems announces more than 10,000 patients treated with the Intracept procedure for Vertebrogenic Low Back Pain
May 02, 2023: Fractyl Health to present Scientific updates on Revita and Rejuva Programs at Upcoming Medical Congresses
Apr 28, 2023: FDA grants breakthrough device status to Innoblative’s SIRA
Apr 26, 2023: HC Surgical Specialists Announces Appointment of Chief Nursing Officer
Apr 24, 2023: Fractyl Health announces the Initiation of a global registry study of the Revita System in patients with inadequately controlled Type 2 Diabetes (T2D)
Apr 17, 2023: Rafaelo meets expectations of a minimally invasive technique
Apr 12, 2023: Medtronic has a layoff in California
Apr 10, 2023: Compal Electronics launches new RFA system AblatePal
Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report
Mar 30, 2023: Relievant Medsystems receives 2023 Gallup Exceptional Workplace Award
Mar 30, 2023: AngioDynamics announces exciting new partnership with Minimax Medical
Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
Mar 16, 2023: NeuroOne successfully completes initial animal implant of novel thin film paddle lead for spinal cord stimulation
Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
Mar 15, 2023: Mima-Pro Scientific receives 510(k) clearance for SurBlate Ablation System
Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
Mar 07, 2023: New interventional oncology data show potential for Aliya pulsed electric field (PEF) system in treatment of solid tumors
Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022
Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting
Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results
Feb 15, 2023: World Leader In Musculoskeletal Health HSS Announces Douglas E. Padgett, MD to become Next Surgeon-in-Chief and Medical Director
Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Full-year Forecasts for Fiscal 2023
Feb 07, 2023: Fractyl Health announces commercial availability of Revita in Germany and successful first procedure at 25th Dusseldorf International Endoscopy Symposium
Feb 06, 2023: Hospital for Special Surgery Announces Rightmove Appoints Marcus Osborne As Ceo
Jan 31, 2023: Fractyl Health provides clinical update on 24-Week data from open label REVITA-T2Di Cohort
Jan 27, 2023: Hospital for Special Surgery Announces Leadership Change
Jan 13, 2023: HSS Florida Continues to Grow With Appointment of Tara M. McCoy As CEO
Jan 05, 2023: Relievant Medsystems announces highest quality of evidence ranking for basivertebral nerve ablation in ASPN back guideline for interventional low back pain treatments
Dec 20, 2022: AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Dec 06, 2022: NeuroOne successfully completes feasibility study with its OneRF ablation system